Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Molecular genetics of human lipoprotein lipase deficiency

  • 66 Accesses

  • 24 Citations

Abstract

Lipoprotein lipase (LPL) hydrolysis the triglyceride core of circulating chylomicrons and very-low-density lipoprotein, and modulates the levels and lipid composition of low and high density lipoproteins. Worldwide, more than 20 mutations in the LPL gene have been identified in patients with familial LPL deficiency. Most of these mutations are clustered in the region encoded by exons 4, 5 and 6 which forms the proposed catalytic domain of LPL. In French Canadians who have the highest reported frequency for LPL deficiency, three common mutations in the LPL gene have been identified which account for approximately 97% of mutant genes in this group. Simple DNA-based tests for the detection of all these mutations have been developed for the screening for carriers of LPL deficiency. This will facilitate further studies of phenotypic expression in heterozygous carriers and assessment of the risk of atherosclerosis in these individuals.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Datta S, Luo C, Li WH et al.: Human Hepatic Lipase. J Biol Chem 283: 1107–1110, 1988

  2. 2.

    Kirchgessner TG, Chuat JC, Heinzmna C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon C, D'Auriol L, Anadalibi A, Schotz MI, Galibert F, Lusis AJ: Organisation of the human lipoprotein gene and evolution of the lipase family. Proc Natl Acad Sci USA 86: 9647–9651, 1989

  3. 3.

    Babirak SP, Iverius PH, Fujimoto WY, Brunzell JD: The detection of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9: 326–334, 1989

  4. 4.

    Brunzell JK: Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: C Scriver, AL Beaudet, WS Sly, D Valle (ed.) The Metabolic Basis of Inherited Disease. McGraw-Hill, New York, 1989, pp 1165–1180

  5. 5.

    Auwerx JH, Babirak SP, Fujimoto WY, Iverius PH, Brunzell JD: Defective enzyme protein in lipoprotein lipase deficiency. Eur J Clin Invest 19: 433–437, 1989

  6. 6.

    Peritz LN, Brunzell JD, Pritchard PH, Jones BR, Hayden MR: Characterization of a lipoprotein lipase class III type defect in hypertriglyceridic cats. Clin Invest Med 13: 259–263, 1990

  7. 7.

    Gagne C, Brun LD, Julien P et al.: Primary lipoprotein-lipaseactivity deficiency: clinical investigation of a French Canadian population. Can Med Assoc J 140: 405–411, 1989

  8. 8.

    Laberge C: Prospectus for Genetic Studies in the French Canadians, with preliminary data on blood groups and consaguinity. Bulletin of the Johns Hopkins Hospital 118: 52, 1966

  9. 9.

    Langlois S, Deeb S, Brunzell JD, Kastelein JJP, Hayden MR: A major insertion accounts for a significant proportion of mutations underlying human lipoprotein lipase deficiency. Proc Natl Acad Sci USA 86: 948–952, 1989

  10. 10.

    Devlin RH, Deed S, Brunzell JD, Hayden MR: Partial gene duplication involving exon-alu interchange results in lipoprotein lipase deficiency. Am J Hum Genet 46: 112–119, 1990

  11. 11.

    Hata A, Robertson M, Emi M, Lalouel JM: Direct Deletion and Automated Sequencing of Individual Alleles after Electrophonetic Strand Separation: Identification of a Common Nonsense Mutation in Exon 9 of the Human Lipoprotein Lipase Gene. Nucl Acid Res 18: 5407–5410, 1990

  12. 12.

    Faustinella F, Chang A, Van Biervliet JP et al.: Catalytic triad residue mutation (Asp156 → Gly) causing familial lipoprotein lipase deficiency: Co-inheritence with a nonsense mutation (Ser447 → Ter) in a Turkish family. J Biol Chem 266: 14418–14424, 1991

  13. 13.

    Winkler FK, D'Arcy A, Hunziker W: Structure of Human Pancreatic Lipase. Nature 343: 771–774, 1990

  14. 14.

    Ma Y, Bruin T, Tuzgol S et al.: Two naturally occurring mutations at the first and second base of Codon Asp156 in the proposed catalytic triad of human lipoprotein lipase — in vivo evidence that Asp156 is essential for catalysis. J Biol Chem, in press

  15. 15.

    Ma Y, Henderson HE, Ven Murthy MR et al.: A Mutation in the Human Lipoprotein Lipase Gene as the Most Common Cause of Familial Chylomicronemia in French Canadians. N Eng J Med 342: 1761–1767, 1991

  16. 16.

    Monsalve MV, Henderson H, Roederer G et al.: A Missense Mutation at Codon 188 of the Human Lipoprotein Lipase Gene is a Frequent Cause of Lipoprotein Lipase Deficiency in Persons of Different Ancestries. J Clin Invest 86: 728–734, 1990

  17. 17.

    Ma Y, Wilson BI, Bijvoet S et al.: A Missense Mutation (Asp250 → Asn) in Exon 6 of the Human Lipoprotein Lipase Gene Cause Type I Hyperlipoproteinemia in Patients of Different Ancestries (submitted)

  18. 18.

    Gordon T, Castelli WP, Hjortlund MC et al.: High Density Lipoprotein as a Protective Factor Against Coronary Heart Disease: The Framingham Study. Am J Med 662: 707–714, 1977

  19. 19.

    Patsch JR, Prasad S, Gotto Jr AM et al.: High Density Lipoprotein: Relationships of the Plasma Levels of this Lipoprotein Species to its Composition, to the Magnitude of Postprandial Lipidemia and to the Activities of Lipoprotein Lipase and Hepatic Lipase. J Clin Invest 80: 341–347, 1987

  20. 20.

    Taskinen MR: Lipoprotein Lipase in Hypertriglyceridemias. In: J Borensztajn (ed.) Lipoprotein Lipase. Chicago 1987, pp. 201–205

  21. 21.

    Beil U, Grundy SM, Crouse JR et al.: Triglyceride and Cholesterol Metabolism in Primary Hypertriglyceridemia. Arteriosclerosis 2: 44–50, 1980

  22. 22.

    Julien P, Normand T, Bergeron J et al.: Prevalence and Origin of Familial Lipoprotein Lipase Deficiency in the French Canadian Population of Quebec. Arterio Thromb 11: 1416a, 1991

  23. 23.

    Benlian P, Loux N, De Gennes JL et al.: A homozygous deletion of exon 9 in the lipoprotein lipase gene causes type I hyperlipoproteinemia. Arterio Thromb 11: 1465a, 1991

  24. 24.

    Gotoda T, Murase T, Ishibashi S et al.: Splicing, nonsense and missense mutations in familial lipoprotein lipase deficiency. Arteriosclerosis 10: 833a, 1990

  25. 25.

    Hata A, Emi M, Luc G et al.: Compound heterozygote for lipoprotein lipase deficiency: Ser → Thr241 and transition in 3′ splice site of intron 2 (AGE AA) in the lipoprotein lipase gene. Am J Hum Genet 47: 721–726, 1990

  26. 26.

    Henderson HH, Devlin R, Peterson J et al.: Frameshift mutation in exon 3 of the lipoprotein lipase gene. Mol Biol Med 7: 511–517, 1990

  27. 27.

    Deeb SS, Reina M, Peterson J et al.: Gene mutations in patients with lipoprotein lipase deficiency. Arterio Thromb 11: 1418a, 1991

  28. 28.

    Emi M, Hata AM, Robertson M et al.: Lipoprotein lipase deficiency resulting from a nonsense mutation in exon 3 of the lipoprotein lipase gene. Am J Hum Genet 47: 107–111, 1990

  29. 29.

    Ishimura-Oka K, Semenkovich CF, Faustinella F et al.: Identification of compound heterozygotes for lipoprotein lipase deficiency in three unrelated families. Arterio Thromb 11: 1415a, 1991

  30. 30.

    Funke H, Wiebusch H, Paulweber B, Assman G: Identification of the molecular defect in a patient with type I hyperlipidemia. Arterosclerosis 10(5): 830(A), 1990

  31. 31.

    Ameis D, Kobayashi J, Davis RC et al.: Familial chylomicronemia (type 1 hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene. J Clin Invest 87: 1165–1170, 1991

  32. 32.

    Bruin T, Kastelein JJP, Monsalve MV et al.: A novel missense in the gene for lipoprotein lipase (LPL) underlying severe hyper chylomicronemia in a kindred of Dutch descent. 55th Meeting of the European Atherosclerosis Society, Brugge, A 91, 1990

  33. 33.

    Beg OU, Meng MS, Skarlatos SI et al.: Lipoprotein lipaseBothozda: A single amino acid substitution (ala176 → Thr) leads to abnormal heparin binding and loss of enzymic activity. Proc Natl Acad Sci USA 87: 3474–3478, 1990

  34. 34.

    Emi M, Wilson DE, Iverius PH et al.: Missense mutation (Gly → Glu153) of human lipoprotein lipase imparting functional deficiency. J Biol Chem 265: 5910–5916, 1990

  35. 35.

    Henderson HE, Ma Y, Hassan MF et al.: Amino acid subsitution (Ile174 → Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands: Support for a multicentric origin. J Clin Invest 87: 2005–2011, 1991

  36. 36.

    Dichek HL, Fojo SS, Beg OU et al.: Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome. J Biol Chem 266: 473–477, 1991

  37. 37.

    Lohse P, Lohse P, Beg OU et al.: Familial chylomicronemia: Identification of a unique patient homozygote for two separate mutations in the LPL gene. Arterio Thromb 11: 1415a, 1991

  38. 38.

    Hata A, Robertson H, Iverwis PH, Hegele R, Calouel JM: Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a com mon nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucl Aud Res 18: 5407–5411, 1990

Download references

Author information

Correspondence to Michael R. Hayden.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hayden, M.R., Ma, Y. Molecular genetics of human lipoprotein lipase deficiency. Mol Cell Biochem 113, 171–176 (1992). https://doi.org/10.1007/BF00231536

Download citation

Key words

  • lipoprotein lipase
  • gene mutations
  • French Canadians
  • triglycerides
  • molecular genetics